Positron emission tomography in bronchioloalveolar carcinoma of the lung

European Journal of Surgical Oncology

Volumn 38, Issue 12, 2012, Pages 1156-1160

  Huang, T W ^a   Lin, L F ^a   Hsieh, C M ^a   Cheng, Y L ^a   Chang, H ^a   Tzao, C ^a   Lee, S C ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Lung cancer; PET CT; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG BRONCHIOLOALVEOLAR CARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84868384209     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.08.020     Document Type: Article

References (31)

1. W.D. Travis, K. Garg, and W.A. Franklin Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma J Clin Oncol 23 2005 3279 3287
2. W.L. Read, N.C. Page, R.M. Tierney, J.F. Piccirillo, and R. Govindan The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database Lung Cancer 45 2004 137 142
3. M.I. Ebright, M.F. Zakowski, and J. Martin Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma Ann Thorac Surg 74 2002 1640 1646
4. R.J. Cerfolio, B. Ojha, A.S. Bryant, C.S. Bass, A.A. Bartalucci, and J.M. Mountz The role of FDG-PET scan in staging patients with nonsmall cell carcinoma Ann Thorac Surg 76 2003 861 866
5. R.J. Cerfolio, B. Ojha, A.S. Bryant, V. Raghuveer, J.M. Mountz, and A.A. Bartolucci The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer Ann Thorac Surg 78 2004 1017 1023
6. B.S. Halpern, C. Schiepers, and W.A. Weber Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion Chest 128 2005 2289 2297
7. R.J. Cerfolio, A.S. Bryant, B. Ohja, and A.A. Bartolucci The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival J Thorac Cardiovasc Surg 130 2005 151 159
8. A. Davies, C. Tan, and C. Paschalides FDG PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients Lung Cancer 55 2007 75 78
9. R.J. Downey, T. Akhurst, and M. Gonen Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection J Clin Oncol 22 2004 3255 3260
10. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J Nucl Med 43 2002 39 45
11. 18F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma Cancer 107 2006 2468 2473
12. 18F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC) Eur J Nucl Med Mol Imaging 37 2010 691 698
13. M. Noguchi, A. Morikawa, and M. Kawasaki Small adenocarcinoma of the lung. Histologic characteristics and prognosis Cancer 75 1995 2844 2852
14. Songtao Liu, Hongxia Cheng, and Shuzhan Yao The clinical application value of PET/CT in adenocarcinoma with bronchioloalveolar carcinoma features Ann Nucl Med 24 2010 541 547
15. H.K. Park, K. Jeon, and W.-J. Koh Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT Respirology 15 2010 1179 1184
16. 18F fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer Respirology 15 2010 1174 1178
17. N.C. Gupta, J. Maloof, and E. Gunel Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET J Nucl Med 37 1996 943 948
18. B. Goodgame, G.A. Pillot, and Z. Yang Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer J Thorac Oncol 3 2008 130 134
19. F.X. Hanin, M. Lonneux, and J. Cornet Prognostic value of FDG uptake in early stage non-small cell lung cancer Eur J Cardiothorac Surg 33 2008 819 823
20. H. Vesselle, J.D. Freeman, and L. Wiens Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role Clin Cancer Res 13 2007 3255 3263
21. R.J. Downey, T. Akhurst, M. Gonen, B. Park, and V. Rusch Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer J Thorac Cardiovasc Surg 133 2007 1419 1427
22. B.T. Kim, Y. Kim, and K.S. Lee Localized form of bronchioloalveolar carcinoma: FDG PET findings AJR Am J Roentgenol 170 1998 935 939
23. N. Al-Sarraf, R. Aziz, and K. Gately Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography Eur J Cardiothorac Surg 33 2008 104 109
24. R.J. Cerfolio, A.S. Bryant, and M.A. Eloubeidi Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study Chest 130 2006 1791 1795
25. H. Kitamura, Y. Kameda, and N. Nakamura Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen Am J Surg Pathol 20 1996 553 562
26. K. Nakanishi, T. Kawai, F. Kumaki, S. Hiroi, M. Mukai, and E. Ikeda Survivin expression in atypical adenomatous hyperplasia of the lung Am J Clin Pathol 120 2003 712 719
27. R.S. Saad, Y. Liu, H. Han, R.J. Landreneau, and J.F. Silverman Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung Mod Pathol 17 2004 1235 1242
28. V.A. Miller, M.G. Kris, and N. Shah Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer J Clin Oncol 22 2004 1103 1119
29. W. Pao, V. Miller, and M. Zakowski EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 101 2004 13306 13311
30. A. Marchetti, C. Martella, and L. Felicioni EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment J Clin Oncol 23 2005 857 865
31. D.R. Gandara, H. West, and K. Chansky Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition Clin Cancer Res 10 2004 4205s 4209s